Contracts Finder · Tender
Flow Cytometer for High-dimensional Cell Analysis 2024
A public procurement published by The University of Warwick via Contracts Finder.
- —
- Award value
- —
- Tender value
- 0
- Suppliers
- 0
- Awards
- 1
- Notices
- Tender
- Stage
Overview
The University of Warwick has a requirement to purchase a state-of-the-art flow cytometer in the Biomedical Sciences Division of Warwick Medical School. For more information please refer to the tender pack which can be accessed here https://in-tendhost.co.uk/universityofwarwick once you have expressed an interest. The University of Warwick is not a contracting authority for the purposes of the Public Contracts Regulations 2015 (as amended) and its procurement activities are not subject to the Public Contracts Regulations 2015 or the obligations under the European Public Procurement Directives, including the European Remedies Directive. Advertisement of any contract in the Off…
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Tender
- Status
- active
- CPV classification
- 38434510 — Cytometers
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 9 Aug 2024
- Last updated
- 9 Aug 2024
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from The University of Warwick
FAQs about this procurement
Who is the buyer for "Flow Cytometer for High-dimensional Cell Analysis 2024"?
Flow Cytometer for High-dimensional Cell Analysis 2024 is a UK public-sector procurement published by The University of Warwick via Contracts Finder.
Has "Flow Cytometer for High-dimensional Cell Analysis 2024" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
When was "Flow Cytometer for High-dimensional Cell Analysis 2024" published?
It was first published on 9 Aug 2024 and last updated on 9 Aug 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable